Paleo Diet 8wk Feasibility in Overweight Adults
Eight Week ad Libitum Self-prepared Paleo Diet and Cardiometabolic Disease Risk Factors in Overweight Adults
1 other identifier
interventional
21
1 country
2
Brief Summary
Overweight, physically inactive but otherwise healthy adults habitually eating a traditional Western diet will follow an ad libitum self-administered Paleo diet for 8-weeks. Blood and body composition will be measured before and after the intervention period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2015
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 19, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2015
CompletedFirst Submitted
Initial submission to the registry
January 16, 2019
CompletedFirst Posted
Study publicly available on registry
January 24, 2019
CompletedJanuary 24, 2019
January 1, 2019
3 months
January 16, 2019
January 22, 2019
Conditions
Outcome Measures
Primary Outcomes (5)
Serum cytokines
Serum measurement of interleukin (IL)-4 (pg/dL), IL-10 (pg/dL), interferon (INF)-gamma (pg/dL), tumor necrosis factor (TNF; pg/dL)
Change from pre-intervention (week zero) and post-intervention (upon completion of week 8)
Serum growth factor
Serum measurement of brain derived neurotrophic factor (BDNF; ng/mL)
Change from pre-intervention (week zero) and post-intervention (upon completion of week 8)
Serum biomarkers of energy homeostasis
Serum fibroblast growth factor (FGF)-21 (pg/mL) and adiponectin (pg/mL)
Change from pre-intervention (week zero) and post-intervention (upon completion of week 8)
Serum glucose metabolism biomarkers
leptin (mg/dL), glucagon-like peptide (GLP)-1 (mg/dL), resistin (mg/dL), insulin (mg/dL), Gastric inhibitory polypeptide (GIP; mg/dL), glucagon (mg/dL), visfatin (mg/dL), ghrelin (mg/dL), plasminogen activator inhibitor (PAI)-1 (mg/dL), C-peptide (mg/dL)
Change from pre-intervention (week zero) and post-intervention (upon completion of week 8)
Serum adipokines
Serum omentin (ng/mL) and nesfatin (ng/mL)
Change from pre-intervention (week zero) and post-intervention (upon completion of week 8)
Secondary Outcomes (7)
Waist and hip circumference
Change from pre-intervention (week zero) and post-intervention (upon completion of week 8)
Subcutaneous body fat
Change from pre-intervention (week zero) and post-intervention (upon completion of week 8)
Dietary composition
Change from pre-intervention (week zero) and post-intervention (upon completion of week 8)
Dietary energy intake
Change from pre-intervention (week zero) and post-intervention (upon completion of week 8)
Blood pressure
Change from pre-intervention (week zero) and post-intervention (upon completion of week 8)
- +2 more secondary outcomes
Study Arms (1)
Dietary intervention
EXPERIMENTALAll participants will follow an ad libitum self-administered Paleo diet for 8-weeks
Interventions
Participants provided with a brochure providing a thorough description of the diet, \~8 example recipes for each meal (i.e. breakfast, lunch, dinner, and snacks) included as a sample menu, and guidance to assist in shopping and self-preparation of food for the prescribed diet and to improve adherence. Diet consisted of following the popular "paleolithic" diet
Eligibility Criteria
You may qualify if:
- Age: 18-55 years
- BMI \> 25 kg/m2
- Currently consuming a typical Western diet (high carbohydrate, low fat diet), which will be assessed using the 3-day dietary record (public domain)
You may not qualify if:
- known cardiovascular, metabolic (including type I or type II diabetes), or respiratory disease
- smoking and/or smokeless tobacco users
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Houstonlead
- Chatham Universitycollaborator
Study Sites (2)
Chatham University
Pittsburgh, Pennsylvania, 15232, United States
University of Houston
Houston, Texas, 77204, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Andres Carrillo
Chatham University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asssitant Professor
Study Record Dates
First Submitted
January 16, 2019
First Posted
January 24, 2019
Study Start
January 19, 2015
Primary Completion
April 14, 2015
Study Completion
April 14, 2015
Last Updated
January 24, 2019
Record last verified: 2019-01